These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2474672)
1. Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein. Coelingh KV; Tierney EL J Virol; 1989 Sep; 63(9):3755-60. PubMed ID: 2474672 [TBL] [Abstract][Full Text] [Related]
2. Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. van Wyke Coelingh K; Tierney EL J Virol; 1989 Jan; 63(1):375-82. PubMed ID: 2462062 [TBL] [Abstract][Full Text] [Related]
3. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus. van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256 [TBL] [Abstract][Full Text] [Related]
4. Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites. Coelingh KV; Winter CC J Virol; 1990 Mar; 64(3):1329-34. PubMed ID: 1689394 [TBL] [Abstract][Full Text] [Related]
5. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404 [TBL] [Abstract][Full Text] [Related]
6. Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. Toyoda T; Gotoh B; Sakaguchi T; Kida H; Nagai Y J Virol; 1988 Nov; 62(11):4427-30. PubMed ID: 2459417 [TBL] [Abstract][Full Text] [Related]
7. The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Portner A; Scroggs RA; Naeve CW Virology; 1987 Apr; 157(2):556-9. PubMed ID: 2435061 [TBL] [Abstract][Full Text] [Related]
8. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. Tsurudome M; Nishio M; Komada H; Bando H; Ito Y Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038 [TBL] [Abstract][Full Text] [Related]
9. Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. Neyt C; Geliebter J; Slaoui M; Morales D; Meulemans G; Burny A J Virol; 1989 Feb; 63(2):952-4. PubMed ID: 2463386 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Crowe JE; Firestone CY; Crim R; Beeler JA; Coelingh KL; Barbas CF; Burton DR; Chanock RM; Murphy BR Virology; 1998 Dec; 252(2):373-5. PubMed ID: 9878616 [TBL] [Abstract][Full Text] [Related]
11. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities. van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318 [TBL] [Abstract][Full Text] [Related]
12. Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies. Rydbeck R; Orvell C; Löve A; Norrby E J Gen Virol; 1986 Aug; 67 ( Pt 8)():1531-42. PubMed ID: 2426392 [TBL] [Abstract][Full Text] [Related]
13. Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles. Ray R; Compans RW J Gen Virol; 1987 Feb; 68 ( Pt 2)():409-18. PubMed ID: 3029283 [TBL] [Abstract][Full Text] [Related]
14. Identification and partial purification of the fusion protein of avian paramyxovirus type 3. Anderson CL; Russell PH Arch Virol; 1989; 108(3-4):295-300. PubMed ID: 2481433 [TBL] [Abstract][Full Text] [Related]
15. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies. Orvell C; Rydbeck R; Löve A J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131 [TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus. Chambers P; Millar NS; Emmerson PT J Gen Virol; 1986 Dec; 67 ( Pt 12)():2685-94. PubMed ID: 3025345 [TBL] [Abstract][Full Text] [Related]
18. Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. Yusoff K; Nesbit M; McCartney H; Meulemans G; Alexander DJ; Collins MS; Emmerson PT; Samson AC J Gen Virol; 1989 Nov; 70 ( Pt 11)():3105-9. PubMed ID: 2479718 [TBL] [Abstract][Full Text] [Related]
19. Nucleotide sequence of the coding and flanking regions of the human parainfluenza virus type 3 fusion glycoprotein gene. Côté MJ; Storey DG; Kang CY; Dimock K J Gen Virol; 1987 Apr; 68 ( Pt 4)():1003-10. PubMed ID: 3033123 [TBL] [Abstract][Full Text] [Related]
20. Antigenic variation in the hemagglutinin-neuraminidase protein of human parainfluenza type 3 virus. van Wyke Coelingh KL; Winter C; Murphy BR Virology; 1985 Jun; 143(2):569-82. PubMed ID: 2414910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]